-
(1S)-1-[(2R)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl]-2-{[(2S)-2-[(2S)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl]-2-hydroxyethyl]amino}ethan-1-ol hydrochloride
-
ChemBase ID:
154880
-
Molecular Formular:
C22H26ClF2NO4
-
Molecular Mass:
441.8959464
-
Monoisotopic Mass:
441.15184244
-
SMILES and InChIs
SMILES:
c1cc2c(cc1F)CC[C@@H](O2)[C@H](CNC[C@@H]([C@@H]1CCc2cc(ccc2O1)F)O)O.Cl
Canonical SMILES:
O[C@H]([C@@H]1CCc2c(O1)ccc(c2)F)CNC[C@@H]([C@H]1CCc2c(O1)ccc(c2)F)O.Cl
InChI:
InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H/t17-,18-,21-,22+;/m0./s1
InChIKey:
JWEXHQAEWHKGCW-BIISKSHESA-N
-
Cite this record
CBID:154880 http://www.chembase.cn/molecule-154880.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1S)-1-[(2R)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl]-2-{[(2S)-2-[(2S)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl]-2-hydroxyethyl]amino}ethan-1-ol hydrochloride
|
|
|
IUPAC Traditional name
|
l-nebivolol hydrochloride
|
|
|
Synonyms
|
Narbivolol
|
Nebilet
|
R-65824
|
rel-(aR,a′R,2R,2′S)-a,a′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] hydrochloride
|
Nebivolol hydrochloride
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
13.520145
|
H Acceptors
|
5
|
H Donor
|
3
|
LogD (pH = 5.5)
|
0.19658114
|
LogD (pH = 7.4)
|
1.7054241
|
Log P
|
3.208403
|
Molar Refractivity
|
103.3172 cm3
|
Polarizability
|
40.23752 Å3
|
Polar Surface Area
|
70.95 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
N1915
|
Biochem/physiol Actions Nebivolol is a competitive, highly selective b1-receptor antagonist with mild vasodialating properties, possibly due to an interaction with the L-arginine/ NO pathway, and is used for treatment of essential hypertension. It is 40-fold selective for β1 vs. β2, and lacks ISA (intrinsic sympathomimetic activity). |
PATENTS
PATENTS
PubChem Patent
Google Patent